Clinical Drug Development

Clinical Development: Path to Market

Start with the end in mind.

Understanding the safety, efficacy, technical and commercial characteristics needed for a product to be successful is criticial when mapping the clinical development path. Pre clinical requirements, price forecasts, market access forecasts, target patient group identification, trials, endpoints needed, developmemt cost and time all go into a clear development plan. At Armstrong Clinical we have the expertise to help you generate Target Product Profile (TPP) and forecast a clinical development plan that maps your path to market for your target indication. Clinical development objectives required each stage development, objective, targeted decision gates at critical junctures help provide confidence in development forecasts, expectations and certainty the strategy for the product is on the right track.

Armstrong Clinical will help define the smartest strategic route tailored to achieve your development and commercial objectives and ensure you capture the right data specific for your product, indication, cost and time targets. Our specialists clinical development, pricing and translational medicine will help ensure you are capturing the right information in the most effective means to enable you to confidently progress to the next stage of development and beyond.

Contact us for this servicePhase I & IIa Study Designs